L-asparaginase is currently used in treating lymphoblastic lymphoma, acute lymphoblastic leukemia (ALL), and relapsed acute myeloid leukemia (AML) [43, 44]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.